Loading data
GYGYNasdaq
| Unit: USD | FY2025 | FY2024 |
|---|---|---|
| Revenue | 58.51 k USD | 14.88 k USD |
| Cost of revenue | 53.45 k USD | 2.31 k USD |
| Gross profit | 5.06 k USD | 12.57 k USD |
| Research and development expense | 515.79 k USD | 898.72 k USD |
| Operating profit | -1.07 m USD | -1.53 m USD |
| Profit before tax | -783.79 k USD | -1.85 m USD |
| Net income (reported basis) | -783.79 k USD | -1.85 m USD |
| Basic earnings per share | -0.05 USD/share | -0.12 USD/share |
| Diluted earnings per share | -0.05 USD/share | -0.12 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.